Evidence-based · Educational only•
36+ Peptides indexed•
Free research library•
Free newsletter — subscribe below•
★ = FDA-approved medical indication•
Not medical advice — always consult a clinician•
Evidence-based · Educational only•
36+ Peptides indexed•
Free research library•
Free newsletter — subscribe below•
★ = FDA-approved medical indication•
Not medical advice — always consult a clinician•
Peptide Knowledge Center
All peptides

Lanreotide

Also known as: Somatuline
FDA-Approved

Lanreotide is a somatostatin analog used for acromegaly and neuroendocrine tumors.

Buy Lanreotide on American Peptides

Affiliate link — we may earn a commission at no extra cost to you.

Overview

Lanreotide is a somatostatin analog used for acromegaly and neuroendocrine tumors.

FDA Approval Status

Approved by the FDA for at least one medical indication (see approved uses below).

Mechanism of Action

Somatostatin receptor agonism.

Current Research

CLARINET and other trials support use.
Research strength: Strong

Potential Medical Uses

  • Acromegaly
  • Gastroenteropancreatic NETs

Potential Benefits

  • Long dosing interval

Known Side Effects

  • GI symptoms
  • Gallstones

Contraindications

  • Hypersensitivity

Drug Interactions

  • Insulin

Administration Methods

  • Deep subcutaneous injection every 4 weeks

Half-life

~25 days (depot)

Reconstitution

Prefilled syringe.

Storage & Handling

Refrigerate.

References & Sources

Frequently Asked Questions

Information on this page is educational and general in nature. It is not medical advice. Consult a qualified healthcare professional before making any medical decisions.